<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">Large scale drug and phytomedicine repurposing is being currently investigated as it is plausible that anti-retroviral therapy may also be effective against SARS coronavirus [
 <xref rid="bib57" ref-type="bibr">[57]</xref>, 
 <xref rid="bib58" ref-type="bibr">[58]</xref>, 
 <xref rid="bib59" ref-type="bibr">[59]</xref>, 
 <xref rid="bib60" ref-type="bibr">[60]</xref>]. ‘BhAVI-23’ displayed prominent inhibition of HIV-1 RT activity as well as infectivity of P1 (vir) phage thus ascertaining its anti-viral potential. The reverse transcriptase assay based upon HIV-1 RT has been reported earlier as potentially beneficial for the assessment of RT activity from different retroviruses as well as screening tool for the prospective RT inhibitors [
 <xref rid="bib61" ref-type="bibr">61</xref>].
</p>
